Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1684

1.

Molecular Epidemiology of Ceftriaxone Non-Susceptible Enterobacterales Isolates in an Academic Medical Center in the United States.

Tamma PD, Shahara SL, Pana ZD, Amoah J, Fisher SL, Tekle T, Doi Y, Simner PJ.

Open Forum Infect Dis. 2019 Aug 11. pii: ofz353. doi: 10.1093/ofid/ofz353. [Epub ahead of print]

PMID:
31401649
2.

Patient-to-patient transmission of KPC variants with reduced ceftazidime-avibactam susceptibility.

Munoz-Price LS, Reeme AE, Buchan BW, Mettus RT, Mustapha MM, Van Tyne D, Shields RK, Doi Y.

Antimicrob Agents Chemother. 2019 Jul 22. pii: AAC.00955-19. doi: 10.1128/AAC.00955-19. [Epub ahead of print]

PMID:
31332070
3.

Fosfomycin for treatment of multidrug-resistant pathogens causing urinary tract infection: A real-world perspective and review of the literature.

Babiker A, Clarke L, Doi Y, Shields RK.

Diagn Microbiol Infect Dis. 2019 Jun 24. pii: S0732-8893(19)30223-8. doi: 10.1016/j.diagmicrobio.2019.06.008. [Epub ahead of print]

PMID:
31307867
4.

Severe Complications from an Unexpectedly High Serum Mycophenolic Acid Concentration in a Patient with Renal Failure Secondary to Lupus Nephritis: A Case Report.

Doi Y, Kitayama H, Yamada M, Miyama Y.

Case Rep Nephrol Dial. 2019 Jun 4;9(2):72-78. doi: 10.1159/000500516. eCollection 2019 May-Aug.

5.

Clinical Profile of Thromboembolic Events in Patients With Hypertrophic Cardiomyopathy in a Regional Japanese Cohort - Results From Kochi RYOMA Study.

Hirota T, Kubo T, Baba Y, Ochi Y, Takahashi A, Yamasaki N, Hamashige N, Yamamoto K, Kondo F, Bando K, Yamada E, Furuno T, Yabe T, Doi YL, Kitaoka H.

Circ J. 2019 Jul 25;83(8):1747-1754. doi: 10.1253/circj.CJ-19-0186. Epub 2019 Jun 29.

6.

The Pitt Bacteremia Score Predicts Mortality in Non-Bacteremic Infections.

Henderson H, Luterbach CL, Cober E, Richter SS, Salata RA, Kalayjian RC, Watkins RR, Doi Y, Kaye KS, Evans S, Fowler VG, Bonomo RA, Harris A, Napravnik S, van Duin D.

Clin Infect Dis. 2019 Jun 19. pii: ciz528. doi: 10.1093/cid/ciz528. [Epub ahead of print]

PMID:
31219148
7.

Correction to: Glycerol metabolism and its regulation in lactic acid bacteria.

Doi Y.

Appl Microbiol Biotechnol. 2019 Jul;103(13):5459. doi: 10.1007/s00253-019-09930-9.

PMID:
31147755
8.

Reduced ceftazidime and ertapenem susceptibility due to production of OXA-2 in Klebsiella pneumoniae ST258.

Iovleva A, Mettus RT, McElheny CL, Mustapha MM, Van Tyne D, Shields RK, Pasculle AW, Cooper VS, Doi Y.

J Antimicrob Chemother. 2019 Aug 1;74(8):2203-2208. doi: 10.1093/jac/dkz183.

PMID:
31127290
9.

Use of a cohorting-unit and systematic surveillance cultures to control a Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae outbreak.

Reeme AE, Bowler SL, Buchan BW, Graham MB, Behrens E, Singh S, Hong JC, Arvan J, Hyke JW, Palen L, Savage S, Seliger H, Huerta S, Ledeboer NA, Kotay S, Mathers AJ, Cooper VS, Mustapha MM, Mettus RT, Doi Y, Munoz-Price LS.

Infect Control Hosp Epidemiol. 2019 Jul;40(7):767-773. doi: 10.1017/ice.2019.99. Epub 2019 May 14.

PMID:
31084655
10.

Left ventricular assist device-associated endocarditis involving multiple clones of Staphylococcus aureus with distinct antimicrobial susceptibility patterns.

Harada S, Aoki K, Okamoto K, Kinoshita O, Nawata K, Ishii Y, Tateda K, Sasaki M, Saga T, Doi Y, Yotsuyanagi H, Moriya K, Ono M.

Int J Infect Dis. 2019 Jul;84:44-47. doi: 10.1016/j.ijid.2019.05.001. Epub 2019 May 7.

11.

Glycerol metabolism and its regulation in lactic acid bacteria.

Doi Y.

Appl Microbiol Biotechnol. 2019 Jul;103(13):5079-5093. doi: 10.1007/s00253-019-09830-y. Epub 2019 May 8. Review. Erratum in: Appl Microbiol Biotechnol. 2019 May 31;:.

PMID:
31069487
12.

Plasmid Carrying bla CTX-M-2 and bla GES-1 in Extensively Drug-Resistant Pseudomonas aeruginosa from Cerebrospinal Fluid.

Ballaben AS, Galetti R, Andrade LN, Ferreira JC, Garcia DO, da Silva P, Doi Y, Darini ALC.

Antimicrob Agents Chemother. 2019 Jun 24;63(7). pii: e00186-19. doi: 10.1128/AAC.00186-19. Print 2019 Jul. No abstract available.

PMID:
31061147
13.

Clinical characteristics and outcomes of community and hospital-acquired Acinetobacter baumannii bacteremia.

Chusri S, Chongsuvivatwong V, Silpapojakul K, Singkhamanan K, Hortiwakul T, Charernmak B, Doi Y.

J Microbiol Immunol Infect. 2019 Apr 12. pii: S1684-1182(18)30188-9. doi: 10.1016/j.jmii.2019.03.004. [Epub ahead of print]

14.

The use of Online Tools for Antimicrobial Resistance Prediction by Whole Genome Sequencing in MRSA and VRE.

Babiker A, Mustapha MM, Pacey MP, Shutt KA, Ezeonwuka CD, Ohm SL, Cooper VS, Marsh JW, Doi Y, Harrison LH.

J Glob Antimicrob Resist. 2019 Apr 18. pii: S2213-7165(19)30095-5. doi: 10.1016/j.jgar.2019.04.006. [Epub ahead of print]

PMID:
31005733
15.

Adjunctive therapy of intravenous colistin to intravenous tigecycline for adult patients with non-bacteremic post-surgical intra-abdominal infection due to carbapenem-resistant Acinetobacter baumannii.

Chusri S, Singkhamanan K, Wanitsuwan W, Suphasynth Y, Kositpantawong N, Panthuwong S, Doi Y.

J Infect Chemother. 2019 Sep;25(9):681-686. doi: 10.1016/j.jiac.2019.03.017. Epub 2019 Apr 17.

PMID:
31003954
16.

Long-term storage of PEGylated liposomal oxaliplatin with improved stability and long circulation times in vivo.

Doi Y, Shimizu T, Ishima Y, Ishida T.

Int J Pharm. 2019 Jun 10;564:237-243. doi: 10.1016/j.ijpharm.2019.04.042. Epub 2019 Apr 16.

PMID:
31002935
17.

Hybrid simulation training utilizing augmented reality and simulator for interprofessional advanced life support training.

Komasawa N, Ohashi T, Take A, Doi Y, Kadoyama K, Terasaki F, Dote T, Akazawa C.

J Clin Anesth. 2019 Nov;57:106-107. doi: 10.1016/j.jclinane.2019.04.009. Epub 2019 Apr 5. No abstract available.

PMID:
30959418
18.

Impact of salt taste dysfunction on interdialytic weight gain for hemodialysis patients; a cross-sectional study.

Tanaka M, Nishiwaki H, Kado H, Doi Y, Ihoriya C, Omae K, Tamagaki K.

BMC Nephrol. 2019 Apr 5;20(1):121. doi: 10.1186/s12882-019-1312-3.

19.

Blood concentrations and renal clearance of water-soluble vitamins in outpatients with ulcerative colitis.

Iwakawa H, Fukui T, Fukuwatari T, Bamba S, Sasaki M, Tsujikawa T, Doi Y, Shibata K.

Biomed Rep. 2019 Mar;10(3):202-210. doi: 10.3892/br.2019.1191. Epub 2019 Feb 5.

20.

Antimicrobial treatment challenges in the era of carbapenem resistance.

Peri AM, Doi Y, Potoski BA, Harris PNA, Paterson DL, Righi E.

Diagn Microbiol Infect Dis. 2019 Aug;94(4):413-425. doi: 10.1016/j.diagmicrobio.2019.01.020. Epub 2019 Feb 5. Review.

PMID:
30905487
21.

Carcinogenicity of intermediate frequency magnetic field in Tg.rasH2 mice.

Nishimura I, Doi Y, Imai N, Kawabe M, Mera Y, Shiina T.

Bioelectromagnetics. 2019 Apr;40(3):160-169. doi: 10.1002/bem.22177. Epub 2019 Mar 15.

22.

A Primer on AmpC Beta-Lactamases: Necessary Knowledge for an Increasingly Multidrug-Resistant World.

Tamma PD, Doi Y, Bonomo RA, Johnson JK, Simner PJ; Antibacterial Resistance Leadership Group.

Clin Infect Dis. 2019 Mar 6. pii: ciz173. doi: 10.1093/cid/ciz173. [Epub ahead of print]

PMID:
30838380
23.

Adherence and Concomitant Medication Use among Patients on Warfarin Therapy: Insight from a Large Pharmacy Dispensing Database in Japan.

Takeuchi M, Nakano S, Tanaka-Mizuno S, Nishiyama C, Doi Y, Arai M, Fujii Y, Matsunaga T, Kawakami K.

Biol Pharm Bull. 2019;42(3):389-393. doi: 10.1248/bpb.b18-00576.

24.

Volumetric modulated arc therapy with robust optimization for larynx cancer.

Miura H, Doi Y, Ozawa S, Nakao M, Ohnishi K, Kenjo M, Nagata Y.

Phys Med. 2019 Feb;58:54-58. doi: 10.1016/j.ejmp.2019.01.012. Epub 2019 Jan 25.

PMID:
30824150
25.

Rivaroxaban for Fully Occlusive Inferior Vena Cava Filter Thrombus.

Sakatani A, Nishio M, Kume K, Doi Y, Hirooka K.

Circ J. 2019 Jun 25;83(7):1616. doi: 10.1253/circj.CJ-18-1141. Epub 2019 Feb 6. No abstract available.

26.

A prospective multicenter observational study evaluating the risk of periendoscopic events in patients using anticoagulants: the Osaka GIANT Study.

Inoue T, Iijima H, Yamada T, Okuyama Y, Takahashi K, Nishida T, Ishihara R, Akasaka T, Kobayashi I, Kuroshima T, Yasunaga Y, Yamamoto K, Nakahara M, Doi Y, Nakajima S, Mukai A, Masuda E, Yoshii S, Hayashi Y, Minamiguchi H, Sakata Y, Yamamoto K, Tsujii M, Takehara T.

Endosc Int Open. 2019 Feb;7(2):E104-E114. doi: 10.1055/a-0754-1997. Epub 2019 Jan 17.

27.

Evaluation of the Accelerate Pheno System for Identification of Acinetobacter Clinical Isolates and Minocycline Susceptibility Testing.

Bowler SL, Towne JW, Humphries RM, Doi Y.

J Clin Microbiol. 2019 Feb 27;57(3). pii: e01711-18. doi: 10.1128/JCM.01711-18. Print 2019 Mar.

PMID:
30651391
28.

Small-Molecule Inhibitor of FosA Expands Fosfomycin Activity to Multidrug-Resistant Gram-Negative Pathogens.

Tomich AD, Klontz EH, Deredge D, Barnard JP, McElheny CL, Eshbach ML, Weisz OA, Wintrode P, Doi Y, Sundberg EJ, Sluis-Cremer N.

Antimicrob Agents Chemother. 2019 Feb 26;63(3). pii: e01524-18. doi: 10.1128/AAC.01524-18. Print 2019 Mar.

PMID:
30642934
29.

The Role of Trimethoprim/Sulfamethoxazole in the Treatment of Infections Caused by Carbapenem-Resistant Enterobacteriaceae.

Luterbach CL, Boshe A, Henderson HI, Cober E, Richter SS, Salata RA, Kalayjian RC, Watkins RR, Hujer AM, Hujer KM, Rudin SD, Domitrovic TN, Doi Y, Kaye KS, Evans S, Fowler VG Jr, Bonomo RA, van Duin D.

Open Forum Infect Dis. 2018 Dec 14;6(1):ofy351. doi: 10.1093/ofid/ofy351. eCollection 2019 Jan.

30.

Effects of KPC Variant and Porin Genotype on the In Vitro Activity of Meropenem-Vaborbactam against Carbapenem-Resistant Enterobacteriaceae.

Wilson WR, Kline EG, Jones CE, Morder KT, Mettus RT, Doi Y, Nguyen MH, Clancy CJ, Shields RK.

Antimicrob Agents Chemother. 2019 Feb 26;63(3). pii: e02048-18. doi: 10.1128/AAC.02048-18. Print 2019 Mar.

PMID:
30617090
31.

Efficacy and safety of ramucirumab plus modified FOLFIRI for metastatic colorectal cancer.

Yoshihiro T, Kusaba H, Makiyama A, Kobayashi K, Uenomachi M, Ito M, Doi Y, Mitsugi K, Aikawa T, Takayoshi K, Esaki T, Shimokawa H, Tsuchihashi K, Ariyama H, Akashi K, Baba E.

Int J Clin Oncol. 2019 May;24(5):508-515. doi: 10.1007/s10147-018-01391-w. Epub 2019 Jan 2.

PMID:
30604155
32.

Rapid Microbial Identification and Antibiotic Resistance Detection by Mass Spectrometric Analysis of Membrane Lipids.

Liang T, Leung LM, Opene B, Fondrie WE, Lee YI, Chandler CE, Yoon SH, Doi Y, Ernst RK, Goodlett DR.

Anal Chem. 2019 Jan 15;91(2):1286-1294. doi: 10.1021/acs.analchem.8b02611. Epub 2019 Jan 4.

PMID:
30571097
33.

A Prospective Study of Acinetobacter baumannii Complex Isolates and Colistin Susceptibility Monitoring by Mass Spectrometry of Microbial Membrane Glycolipids.

Leung LM, McElheny CL, Gardner FM, Chandler CE, Bowler SL, Mettus RT, Spychala CN, Fowler EL, Opene BNA, Myers RA, Goodlett DR, Doi Y, Ernst RK.

J Clin Microbiol. 2019 Feb 27;57(3). pii: e01100-18. doi: 10.1128/JCM.01100-18. Print 2019 Mar.

PMID:
30567747
34.

Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Intravenous Dose of Miridesap in Healthy Japanese Subjects.

Ino H, Doi Y, Liefaard L, Cookson L, Chen C, Itoh H, Igarashi H, Nakano A.

Clin Pharmacol Drug Dev. 2019 Jul;8(5):612-618. doi: 10.1002/cpdd.631. Epub 2018 Dec 17.

PMID:
30556959
35.

VEGF-A Links Angiolymphoid Hyperplasia With Eosinophilia (ALHE) to THSD7A Membranous Nephropathy: A Report of 2 Cases.

Matsumoto A, Matsui I, Namba T, Sakaguchi Y, Mizuno H, Shirayama Y, Shimada K, Hashimoto N, Doi Y, Yamaguchi S, Kubota K, Oka T, Mori D, Akiyama S, Hamano T, Mizui M, Takabatake Y, Kaneko T, Isaka Y.

Am J Kidney Dis. 2019 Jun;73(6):880-885. doi: 10.1053/j.ajkd.2018.10.009. Epub 2018 Dec 13.

PMID:
30554801
36.
37.

Plasma Glucose Level as a Predictor of In-Hospital Mortality in Patients at an Emergency Room: A Retrospective Cohort Study.

Yoshinaga R, Ishikawa S, Ayukawa K, Doi Y.

Diabetes Care. 2019 Jan;42(1):e6-e7. doi: 10.2337/dc18-1978. Epub 2018 Nov 19. No abstract available.

PMID:
30455332
38.

Usefulness of Screening for Abdominal Aortic Aneurysm During Transthoracic Echocardiography in Women ≥50 Years of Age.

Matsumura Y, Ochi Y, Wada M, Hirakawa D, Yamanaka S, Kamioka M, Kitaoka H, Orihashi K, Nakaoka Y, Doi Y, Sugiura T.

Am J Cardiol. 2018 Dec 15;122(12):2147-2150. doi: 10.1016/j.amjcard.2018.08.050. Epub 2018 Sep 22.

PMID:
30360889
39.

New Treatment Options against Carbapenem-Resistant Acinetobacter baumannii Infections.

Isler B, Doi Y, Bonomo RA, Paterson DL.

Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01110-18. doi: 10.1128/AAC.01110-18. Print 2019 Jan. Review.

40.

Successful treatment for various arrhythmias in an older patient treated with pilsicainide for paroxysmal supraventricular tachycardia.

Etoh R, Ishimatsu T, Kawano H, Tomichi Y, Arakawa S, Doi Y, Fukae S, Maemura K.

Geriatr Gerontol Int. 2018 Oct;18(10):1520-1521. doi: 10.1111/ggi.13520. No abstract available.

PMID:
30311445
41.

Postural Orthostatic Tachycardia in a Patient with Type 2 Diabetes with Diabetic Neuropathy.

Tomichi Y, Kawano H, Mukaino A, Chiba A, Doi Y, Arakawa S, Ishimatsu T, Fukae S, Abiru N, Maemura K.

Int Heart J. 2018 Nov 28;59(6):1488-1490. doi: 10.1536/ihj.17-628. Epub 2018 Oct 10.

42.

Clostridioides difficile: a potential source of NpmA in the clinical environment.

Marsh JW, Pacey MP, Ezeonwuka C, Ohm SL, Snyder D, Cooper VS, Harrison LH, Doi Y, Mustapha MM.

J Antimicrob Chemother. 2019 Feb 1;74(2):521-523. doi: 10.1093/jac/dky420. No abstract available.

PMID:
30295814
43.

Unilateral cardiogenic pulmonary edema.

Inotani S, Kubokawa SI, Nakaoka Y, Kotani T, Matsuda H, Yamamoto S, Seki SI, Kawai K, Hamashige N, Doi Y.

J Cardiol Cases. 2017 Nov 27;17(3):85-88. doi: 10.1016/j.jccase.2017.10.004. eCollection 2018 Mar.

44.

Fluoroquinolone Prophylaxis Selects for Meropenem-nonsusceptible Pseudomonas aeruginosa in Patients With Hematologic Malignancies and Hematopoietic Cell Transplant Recipients.

Hakki M, Humphries RM, Hemarajata P, Tallman GB, Shields RK, Mettus RT, Doi Y, Lewis JS.

Clin Infect Dis. 2019 May 30;68(12):2045-2052. doi: 10.1093/cid/ciy825.

PMID:
30256922
45.

Emergence of CMY-2-Producing Salmonella Heidelberg Associated with IncI1 Plasmids Isolated from Poultry in Brazil.

Tiba-Casas MR, Camargo CH, Soares FB, Doi Y, Fernandes SA.

Microb Drug Resist. 2019 Mar;25(2):271-276. doi: 10.1089/mdr.2018.0044. Epub 2018 Sep 25.

PMID:
30256175
46.

Lactic acid fermentation is the main aerobic metabolic pathway in Enterococcus faecalis metabolizing a high concentration of glycerol.

Doi Y.

Appl Microbiol Biotechnol. 2018 Dec;102(23):10183-10192. doi: 10.1007/s00253-018-9351-4. Epub 2018 Sep 19.

PMID:
30232536
47.

Pseudomonas aeruginosa utilizes host polyunsaturated phosphatidylethanolamines to trigger theft-ferroptosis in bronchial epithelium.

Dar HH, Tyurina YY, Mikulska-Ruminska K, Shrivastava I, Ting HC, Tyurin VA, Krieger J, St Croix CM, Watkins S, Bayir E, Mao G, Armbruster CR, Kapralov A, Wang H, Parsek MR, Anthonymuthu TS, Ogunsola AF, Flitter BA, Freedman CJ, Gaston JR, Holman TR, Pilewski JM, Greenberger JS, Mallampalli RK, Doi Y, Lee JS, Bahar I, Bomberger JM, Bayır H, Kagan VE.

J Clin Invest. 2018 Oct 1;128(10):4639-4653. doi: 10.1172/JCI99490. Epub 2018 Sep 10.

48.

Detection of high-risk carbapenem-resistant Klebsiella pneumoniae and Enterobacter cloacae isolates using volatile molecular profiles.

Rees CA, Nasir M, Smolinska A, Lewis AE, Kane KR, Kossmann SE, Sezer O, Zucchi PC, Doi Y, Hirsch EB, Hill JE.

Sci Rep. 2018 Sep 5;8(1):13297. doi: 10.1038/s41598-018-31543-x.

49.

Nonlinear waves in a model for silicate layers.

Archilla JFR, Zolotaryuk Y, Kosevich YA, Doi Y.

Chaos. 2018 Aug;28(8):083119. doi: 10.1063/1.5030376.

PMID:
30180643
50.

Diversity of High-Level Aminoglycoside Resistance Mechanisms among Gram-Negative Nosocomial Pathogens in Brazil.

Ballaben AS, Andrade LN, Galetti R, Ferreira JC, McElheny CL, Mettus RT, da Silva P, de Oliveira Garcia D, Darini ALC, Doi Y.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e01550-18. doi: 10.1128/AAC.01550-18. Print 2018 Nov. No abstract available.

Supplemental Content

Support Center